Yahoo Web Search

Search results

1. • 

     ResMed's (RMD) Q4 Earnings Miss, Revenues Beat Estimates

     Zacks via Yahoo Finance· 9 months ago

     ResMed (RMD) records a robust sales performance in fiscal Q4 backed by the ongoing combined...

2. • 

     ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 (Revised)

     Zacks via Yahoo Finance· 2 months ago

     ResMed, Inc. RMD recently introduced its AirCurve 11 series devices -- the company’s newest bilevel...

3. • 

     ResMed's (RMD) New Buyout Aids Growth Amid Rising Costs

     Zacks via Yahoo Finance· 10 months ago

     ResMed RMD continues to see improvement in patient diagnosis trends in sleep apnea, COPD and asthma....

4. • 

     ResMed (RMD) Gains From Strong Device Sales Amid Macro Woes

     Zacks via Yahoo Finance· 6 months ago

     ResMed RMD is leading the market with its cloud-connected flow generator platforms. However,...

5. • 

     Reasons Why You Should Invest in ResMed (RMD) Stock Now

     Zacks via Yahoo Finance· 2 years ago

     ResMed Inc. RMD is well poised for growth in the coming quarters, backed by strong mask and device...

6. • 

     ResMed (RMD) Q1 Earnings Surpass Estimates, Margins Down

     Zacks via Yahoo Finance· 6 months ago

     ResMed's (RMD) solid revenue growth in the first quarter of fiscal 2024 reflects the strength of...

7. • 

     Here's Why Investors Should Retain ResMed (RMD) Stock for Now

     Zacks via Yahoo Finance· 10 months ago

     ResMed Inc. RMD is gaining investors’ confidence, backed by the prospect of the company’s digital...

8. • 

     The 7 Best CPAP Machines of 2023

     Verywell Health via Yahoo News· 1 year ago

     Dotdash Meredith and Yahoo Inc. may earn commission or revenue on some items through the links below. The ResMed AirSense 10 CPAP machine is a...

9. • 

     Decoding ResMed Inc (RMD): A Strategic SWOT Insight

     GuruFocus.com via Yahoo Finance· 3 months ago

     ResMed Inc (NYSE:RMD) showcases robust revenue growth with a 12% increase in net revenue for Q3 FY2024. Despite a slight dip in gross margin, RMD...

10. • 

      Resmed hails ‘significant victory’ as patent board rules in dispute with NYU

      MedTech Dive via Yahoo Finance· 4 months ago

      Dive Brief: Resmed has claimed a “significant victory” after the U.S. Patent Trial and Appeal Board...